Suppr超能文献

NOD2通过下调TLR通路抑制结直肠癌发生。

NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways.

作者信息

Udden S M Nashir, Peng Lan, Gan Jia-Liang, Shelton John M, Malter James S, Hooper Lora V, Zaki Md Hasan

机构信息

Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA.

Molecular Pathology Core, UT Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Cell Rep. 2017 Jun 27;19(13):2756-2770. doi: 10.1016/j.celrep.2017.05.084.

Abstract

Although NOD2 is the major inflammatory bowel disease susceptibility gene, its role in colorectal tumorigenesis is poorly defined. Here, we show that Nod2-deficient mice are highly susceptible to experimental colorectal tumorigenesis independent of gut microbial dysbiosis. Interestingly, the expression of inflammatory genes and the activation of inflammatory pathways, including NF-κB, ERK, and STAT3 are significantly higher in Nod2 mouse colons during colitis and colorectal tumorigenesis, but not at homeostasis. Consistent with higher inflammation, there is greater proliferation of epithelial cells in hyperplastic regions of Nod2 colons. In vitro studies demonstrate that, while NOD2 activates the NF-κB and MAPK pathways in response to MDP, it inhibits TLR-mediated activation of NF-κB and MAPK. Notably, NOD2-mediated downregulation of NF-κB and MAPK is associated with the induction of IRF4. Taken together, NOD2 plays a critical role in the suppression of inflammation and tumorigenesis in the colon via downregulation of the TLR signaling pathways.

摘要

尽管NOD2是主要的炎症性肠病易感基因,但其在结直肠癌发生中的作用仍不清楚。在此,我们表明Nod2基因缺陷小鼠对实验性结直肠癌发生高度易感,且与肠道微生物生态失调无关。有趣的是,在结肠炎和结直肠癌发生过程中,Nod2基因缺陷小鼠结肠中炎症基因的表达以及包括NF-κB、ERK和STAT3在内的炎症信号通路的激活显著高于稳态时,但在稳态时无此现象。与更高的炎症水平一致,Nod2基因缺陷小鼠结肠增生区域的上皮细胞增殖更为明显。体外研究表明,虽然NOD2在响应MDP时激活NF-κB和MAPK信号通路,但它抑制TLR介导的NF-κB和MAPK激活。值得注意的是,NOD2介导的NF-κB和MAPK下调与IRF4的诱导有关。综上所述,NOD2通过下调TLR信号通路在抑制结肠炎症和肿瘤发生中起关键作用。

相似文献

1
NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways.
Cell Rep. 2017 Jun 27;19(13):2756-2770. doi: 10.1016/j.celrep.2017.05.084.
2
Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Front Immunol. 2022 Sep 15;13:988862. doi: 10.3389/fimmu.2022.988862. eCollection 2022.
3
Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
Mol Cell Biol. 2007 Sep;27(17):6012-25. doi: 10.1128/MCB.00270-07. Epub 2007 Jun 11.
7
Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Gastroenterology. 2013 Dec;145(6):1392-403.e1-8. doi: 10.1053/j.gastro.2013.08.033. Epub 2013 Aug 21.
9
TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury.
J Mol Med (Berl). 2015 Sep;93(9):1033-43. doi: 10.1007/s00109-015-1288-9. Epub 2015 Apr 17.
10
The molecular basis of NOD2 susceptibility mutations in Crohn's disease.
Mucosal Immunol. 2008 Nov;1 Suppl 1(0 1):S5-9. doi: 10.1038/mi.2008.42.

引用本文的文献

1
Dysbiosis and colorectal cancer: conducive factors, biological and molecular role, and therapeutic prospectives.
Explor Target Antitumor Ther. 2025 Jun 27;6:1002329. doi: 10.37349/etat.2025.1002329. eCollection 2025.
3
Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis.
J Clin Invest. 2024 Oct 1;134(22):e179527. doi: 10.1172/JCI179527.
5
NOD2-mediated dual negative regulation of inflammatory responses triggered by TLRs in the gastrointestinal tract.
Front Immunol. 2024 Sep 30;15:1433620. doi: 10.3389/fimmu.2024.1433620. eCollection 2024.
6
The multiple roles of interferon regulatory factor family in health and disease.
Signal Transduct Target Ther. 2024 Oct 9;9(1):282. doi: 10.1038/s41392-024-01980-4.
7
NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis.
Cell Death Dis. 2024 Oct 1;15(10):720. doi: 10.1038/s41419-024-07104-8.
8
Innate immunity gene Nod2 protects mice from orthotopic breast cancer.
Mol Biol Rep. 2024 Sep 17;51(1):988. doi: 10.1007/s11033-024-09927-2.
9
Pyroptosis-associated genes and tumor immune response in endometrial cancer.
Discov Oncol. 2024 Sep 12;15(1):433. doi: 10.1007/s12672-024-01315-3.
10
The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma.
Open Med (Wars). 2024 Aug 10;19(1):20240974. doi: 10.1515/med-2024-0974. eCollection 2024.

本文引用的文献

1
The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense.
Cell Rep. 2015 Dec 1;13(9):1922-36. doi: 10.1016/j.celrep.2015.10.040. Epub 2015 Nov 19.
2
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
World J Gastroenterol. 2014 Dec 21;20(47):17699-708. doi: 10.3748/wjg.v20.i47.17699.
3
NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.
Mucosal Immunol. 2014 Nov;7(6):1312-25. doi: 10.1038/mi.2014.19. Epub 2014 Mar 26.
4
NOD2 polymorphisms associated with cancer risk: a meta-analysis.
PLoS One. 2014 Feb 20;9(2):e89340. doi: 10.1371/journal.pone.0089340. eCollection 2014.
5
NOD proteins: regulators of inflammation in health and disease.
Nat Rev Immunol. 2014 Jan;14(1):9-23. doi: 10.1038/nri3565. Epub 2013 Dec 13.
6
The gut microbiome modulates colon tumorigenesis.
mBio. 2013 Nov 5;4(6):e00692-13. doi: 10.1128/mBio.00692-13.
7
Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis.
Gut Microbes. 2013 May-Jun;4(3):222-31. doi: 10.4161/gmic.24373. Epub 2013 Apr 2.
10
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.
J Clin Invest. 2013 Feb;123(2):700-11. doi: 10.1172/JCI62236. Epub 2013 Jan 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验